Picture a horse running across an open field, the wind blowing his mane, his hooves stamping into the grassy knoll, eyes on ...

The Congress on Controversies in Ophthalmology will be held April 4-5 in Seville, Spain.As the name implies, the unique ...

PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces the first close of its ...

Patient age in uveitis diagnoses and treatment plays a significant role, according to research published in American Journal of Ophthalmology.

A new study identifies Florida spot keratopathy (FSK) as a stable, benign eye condition in pets and suggests a possible link ...

Goniotomy may be a first-line approach to treating pediatric patients with glaucoma secondary to uveitis, with improvements ...

Reports Q3 revenue $9.02M, consensus $4.75M. “Roivant has broadened our clinical pipeline with the newly announced trial of brepocitinib in ...

The global veterinary eye care market size is estimated to grow by USD 1.05 billion from 2024-2028, according to Technavio.

A new study from the Koret School of Veterinary Medicine at Hebrew University has brought new insights into Florida spot ...

Roivant's $7.1B Telavant sale to Roche demonstrated potential, but the company's stock has underperformed. Read my analysis ...

Kate Myrna, DVM, DACVO, discussed the ophthalmologic condition during a session at the 2025 Veterinary Meeting & Expo.

An international study led by the University of Oulu and Oulu University Hospital has identified six genetic regions associated with the inflammation of the eye's iris, also known as anterior uveitis.